Emicizumab inj. 30mg 1.0ml A, Emicizumab inj. 30mg 1.0ml B, Emicizumab inj. 30mg 1.0ml C, Emicizumab inj. 60mg 0.4ml A, Emicizumab inj. 60mg 0.4ml B
Indian Council of Medical Research (ICMR) · Mumbai, Maharashtra · Pharmaceuticals · open
Key facts
- Closing date: 11 Aug 2026
- Status: open
- Ministry: Ministry of Health and Family Welfare
- Department: Department of Health Research
- Office: Mumbai
Description
Tender for supply of Emicizumab injections in various dosages and categories, issued by the Indian Council of Medical Research (ICMR) under the Department of Health Research, Ministry of Health and Family Welfare. The bid is for a total quantity of 40 units, with a bid validity of 180 days from the end date, and includes provisions for MSE and MII purchase preferences.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: Yes
- Documents required: Udyam Certificate, Bidder credentials validation
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Emicizumab inj. 30mg 1.0ml A — Qty: 40 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals